Premature Ejaculation Treatment Market by Drug Type, Type, Dosage Form, Distribution Channel - Global Forecast 2025-2030- Product Image

Sale

Premature Ejaculation Treatment Market by Drug Type, Type, Dosage Form, Distribution Channel - Global Forecast 2025-2030

Report
189 Pages
October 2024
Region: Global
360iResearch™
ID: 4968711

UP TO €684EUR$697USD£569GBP OFF until Dec 31^st 2024

The Premature Ejaculation Treatment Market grew from USD 3.52 billion in 2023 to USD 3.86 billion in 2024. It is expected to continue growing at a CAGR of 9.80%, reaching USD 6.77 billion by 2030.

Premature ejaculation (PE) treatment market encompasses a range of therapeutic solutions aimed at enhancing male sexual health by addressing PE, a prevalent male sexual dysfunction characterized by ejaculation that occurs sooner than desired. The necessity for effective treatment is driven by its significant psychological and relational impacts on affected individuals and their partners. Applications of PE treatment span pharmaceutical solutions, such as selective serotonin reuptake inhibitors (SSRIs) and numbing creams, to psychological interventions like cognitive behavioral therapy. The end-use scope includes individuals diagnosed with PE, healthcare providers, clinics specializing in male sexual health, and pharmaceutical companies. Key factors influencing market growth include advancements in medical technology, increased consumer awareness, and a broader acceptance of open conversations about sexual health. Emerging opportunities lie in personalized treatment approaches and telehealth services that enable remote patient management. However, market limitations include the stigma associated with sexual health issues and potential side effects of pharmacological treatments. Regulatory challenges and the availability of treatment options that lack robust efficacy evidence also pose barriers. Innovations show promise in developing non-pharmacological solutions like wearable devices and evidence-based mobile health applications tailored for symptom tracking and personalized therapy. Additionally, research into novel pharmaceuticals or treatment methods leveraging biotechnology and nanotechnology could unlock new growth avenues. To navigate these challenges, companies should invest in education and awareness campaigns to reduce stigma, prioritize research into side effect mitigation, and explore strategic partnerships for technology integration. As the market evolves, maintaining a patient-centric approach by focusing on improvements in quality of life and treatment accessibility will be vital. The PE treatment market is dynamic, characterized by a growing emphasis on holistic and integrated care solutions that combine modern technology with traditional treatment paradigms, opening up expansive growth and innovation pathways for forward-looking businesses.

Understanding Market Dynamics in the Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Raising governments awareness of premature ejaculation
- Increasing prevalence of premature ejaculation
- Availability of treatment through telehealth
Market Restraints
- Side effects associated with the premature ejaculation treatment
Market Opportunities
- Rising research & development of drugs for treatment
- Increasing strategic collaborations for development of new diagnostic tools
Market Challenges
- Shortage of medical professionals

Exploring Porter’s Five Forces for the Premature Ejaculation Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Premature Ejaculation Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Premature Ejaculation Treatment Market

External macro-environmental factors deeply influence the performance of the Premature Ejaculation Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Premature Ejaculation Treatment Market

The Premature Ejaculation Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Premature Ejaculation Treatment Market, highlighting leading vendors and their innovative profiles. These include Ampio Pharmaceuticals, Inc., Aytu BioPharma, Inc., Bayer AG, Donga Pharmaceutical Co.,Ltd., Eli Lilly and Company, Emcure Pharmaceuticals, Futura Medical PLC, GlaxoSmithKline PLC, Hetero Healthcare Limited, Menarini Group, NeuroHealing Pharmaceuticals Inc., Pfizer Inc., Veru Inc., Wholesome Medtech Private Limited, and zr pharma& GmbH.

Market Segmentation & Coverage

This research report categorizes the Premature Ejaculation Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Type
- Dapoxetine
- Phosphodiesterase Type 5 (PDE5) Inhibitors
- Selective Serotonin Reuptake Inhibitors
- Topical Anesthetics
- Zertane
Type
- Oral Therapies
  - Nonselective Serotonin Reuptake Inhibitor
  - Selective Serotonin Reuptake Inhibitor
- Topical Therapies
Dosage Form
- Pills
- Spray
Distribution Channel
- Hospitals
- Online Pharmacies
- Retail Pharmacies

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Raising governments awareness of premature ejaculation
5.1.1.2. Increasing prevalence of premature ejaculation
5.1.1.3. Availability of treatment through telehealth
5.1.2. Restraints
5.1.2.1. Side effects associated with the premature ejaculation treatment
5.1.3. Opportunities
5.1.3.1. Rising research & development of drugs for treatment
5.1.3.2. Increasing strategic collaborations for development of new diagnostic tools
5.1.4. Challenges
5.1.4.1. Shortage of medical professionals
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Premature Ejaculation Treatment Market, by Drug Type

6.1. Introduction
6.2. Dapoxetine
6.3. Phosphodiesterase Type 5 (PDE5) Inhibitors
6.4. Selective Serotonin Reuptake Inhibitors
6.5. Topical Anesthetics
6.6. Zertane

7. Premature Ejaculation Treatment Market, by Type

7.1. Introduction
7.2. Oral Therapies
7.2.1. Nonselective Serotonin Reuptake Inhibitor
7.2.2. Selective Serotonin Reuptake Inhibitor
7.3. Topical Therapies

8. Premature Ejaculation Treatment Market, by Dosage Form

8.1. Introduction
8.2. Pills
8.3. Spray

9. Premature Ejaculation Treatment Market, by Distribution Channel

9.1. Introduction
9.2. Hospitals
9.3. Online Pharmacies
9.4. Retail Pharmacies

10. Americas Premature Ejaculation Treatment Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Premature Ejaculation Treatment Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Premature Ejaculation Treatment Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. PREMATURE EJACULATION TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. PREMATURE EJACULATION TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
FIGURE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. PREMATURE EJACULATION TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. PREMATURE EJACULATION TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DAPOXETINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PHOSPHODIESTERASE TYPE 5 (PDE5) INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL ANESTHETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ZERTANE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY NONSELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SELECTIVE SEROTONIN REUPTAKE INHIBITOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TOPICAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 45. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 46. CANADA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 48. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 50. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 51. MEXICO PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 64. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 70. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 72. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 73. CHINA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 75. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 77. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 78. INDIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 85. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 87. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. JAPAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 115. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 117. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 118. THAILAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 130. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 131. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. DENMARK PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 136. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 138. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 139. EGYPT PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 140. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 141. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 143. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 144. FINLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 145. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 149. FRANCE PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 150. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 151. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 154. GERMANY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 160. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 161. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 163. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 164. ITALY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 165. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 176. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 178. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 179. NORWAY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 181. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 183. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 184. POLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 186. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 188. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 189. QATAR PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 206. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 209. SPAIN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 221. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 223. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 224. TURKEY PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY ORAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM PREMATURE EJACULATION TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. PREMATURE EJACULATION TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 236. PREMATURE EJACULATION TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Premature Ejaculation Treatment Market, which are profiled in this report, include:

Ampio Pharmaceuticals, Inc.
Aytu BioPharma, Inc.
Bayer AG
Donga Pharmaceutical Co.,Ltd.
Eli Lilly and Company
Emcure Pharmaceuticals
Futura Medical PLC
GlaxoSmithKline PLC
Hetero Healthcare Limited
Menarini Group
NeuroHealing Pharmaceuticals Inc.
Pfizer Inc.
Veru Inc.
Wholesome Medtech Private Limited
zr pharma& GmbH

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	189
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 3.86 Billion
Forecasted Market Value ( USD ) by 2030	$ 6.77 Billion
Compound Annual Growth Rate	9.8%
Regions Covered	Global
No. of Companies Mentioned	15

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3480EUR$3,545USD£2,894GBP €3867EUR$3,939USD£3,216GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6157EUR$6,272USD£5,121GBP €6842EUR$6,969USD£5,690GBP

Understanding Market Dynamics in the Premature Ejaculation Treatment Market

Exploring Porter’s Five Forces for the Premature Ejaculation Treatment Market

Applying PESTLE Analysis to the Premature Ejaculation Treatment Market

Analyzing Market Share in the Premature Ejaculation Treatment Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Premature Ejaculation Treatment Market

Strategic Recommendations for Success in the Premature Ejaculation Treatment Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Premature Ejaculation Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Premature Ejaculation Treatment - Global Strategic Business Report

Premature Ejaculation Treatment Global Market Report 2024

Premature Ejaculation - Pipeline Insight, 2024

Premature Ejaculation Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

About the Premature Ejaculation Drug Market